Advertisement
Screener

ABEONA THERAPEUTICS INC. (ABEO) Net Margin

ABEONA THERAPEUTICS INC. (ABEO) Net Margin

  • 2026-06-30: Net Margin -177.43%.
  • 2026-03-31: Net Margin -195.81%.
  • 2025-12-31: Net Margin -377.49%.
  • 2025-06-30: Net Margin 27208.25%.

Complete source-backed net margin history.

Available history
2010-06-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-177.43%
2026-03-31-195.81%
2025-12-31-377.49%
2025-06-3027208.25%
2023-06-30-475.83%
2022-12-31-10472.06%
2022-06-30-409.70%
2022-03-31-6371.10%
2020-12-31-527.60%
2020-09-30-103.39%
2018-12-31-3626.35%
2018-09-30-960.74%
2018-06-30-1494.87%
2018-03-31-405.31%
2017-12-31-3930.23%
2017-09-30-2439.73%
2017-06-30-3815.21%
2017-03-31-2820.97%
2016-12-31-2735.16%
2016-09-30-1426.09%
2016-06-30-3132.24%
2016-03-31-2359.15%
2015-12-31-1088.37%
2015-09-30-2130.88%
2015-06-30-1458.51%
2015-03-31-775.19%
2014-12-31-5103.85%
2014-09-30-622.46%
2014-06-30-5063.56%
2014-03-31-412.98%
2013-12-31-663.58%
2013-09-30-83.07%
2013-06-30342.61%
2013-03-31333.42%
2012-12-311970.87%
2012-09-30-1706.89%
2012-06-30-1536.23%
2012-03-31-266.30%
2011-12-3156.43%
2011-09-3033.62%
2011-06-30-842.67%
2011-03-31-1266.00%
2010-12-311566.67%
2010-09-30-10014.96%
2010-06-301704.76%

Annual Net Margin

DateNet Margin
2025-12-311223.08%
2023-12-31-1548.23%
2022-12-31-2807.36%
2021-12-31-2831.20%
2020-12-31-842.34%
2018-12-31-1890.29%
2017-12-31-3263.92%
2016-12-31-2460.40%
2015-12-31-1396.73%
2014-12-31-2894.92%
2013-12-31217.87%
2012-12-31-239.15%
2011-12-31-137.68%
2010-12-31-1566.94%

Similar stocks

Stock NameCountryMarket CapPE Ratio
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Evommune, Inc. (EVMN)United States$0.320B-5.10
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Vanda Pharmaceuticals Inc. (VNDA)United States$0.302B-1.35
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40